Atossa Genetics Total Assets 2012-2025 | ATOS
Atossa Genetics total assets from 2012 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
| Atossa Genetics Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $76 |
| 2023 | $96 |
| 2022 | $124 |
| 2021 | $141 |
| 2020 | $43 |
| 2019 | $14 |
| 2018 | $12 |
| 2017 | $8 |
| 2016 | $4 |
| 2015 | $6 |
| 2014 | $12 |
| 2013 | $12 |
| 2012 | $7 |
| 2011 | $3 |
| Atossa Genetics Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $71 |
| 2024-12-31 | $76 |
| 2024-09-30 | $79 |
| 2024-06-30 | $86 |
| 2024-03-31 | $91 |
| 2023-12-31 | $96 |
| 2023-09-30 | $102 |
| 2023-06-30 | $108 |
| 2023-03-31 | $116 |
| 2022-12-31 | $124 |
| 2022-09-30 | $127 |
| 2022-06-30 | $134 |
| 2022-03-31 | $137 |
| 2021-12-31 | $141 |
| 2021-09-30 | $143 |
| 2021-06-30 | $146 |
| 2021-03-31 | $141 |
| 2020-12-31 | $43 |
| 2020-09-30 | $11 |
| 2020-06-30 | $10 |
| 2020-03-31 | $12 |
| 2019-12-31 | $14 |
| 2019-09-30 | $17 |
| 2019-06-30 | $19 |
| 2019-03-31 | $21 |
| 2018-12-31 | $12 |
| 2018-09-30 | $14 |
| 2018-06-30 | $17 |
| 2018-03-31 | $6 |
| 2017-12-31 | $8 |
| 2017-09-30 | $4 |
| 2017-06-30 | $5 |
| 2017-03-31 | $2 |
| 2016-12-31 | $4 |
| 2016-09-30 | $6 |
| 2016-06-30 | $3 |
| 2016-03-31 | $5 |
| 2015-12-31 | $6 |
| 2015-09-30 | $12 |
| 2015-06-30 | $17 |
| 2015-03-31 | $14 |
| 2014-12-31 | $12 |
| 2014-09-30 | $17 |
| 2014-06-30 | $20 |
| 2014-03-31 | $22 |
| 2013-12-31 | $12 |
| 2013-09-30 | $13 |
| 2013-06-30 | $10 |
| 2013-03-31 | $9 |
| 2012-12-31 | $7 |
| 2012-09-30 | $6 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | $0 |
| 2011-09-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.108B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $176.546B | 21.36 |
| Intuitive Surgical (ISRG) | United States | $172.459B | 71.48 |
| Edwards Lifesciences (EW) | United States | $46.523B | 30.86 |
| Alcon (ALC) | Switzerland | $43.184B | 29.18 |
| IDEXX Laboratories (IDXX) | United States | $42.970B | 49.38 |
| DexCom (DXCM) | United States | $31.674B | 47.51 |
| IQVIA Holdings (IQV) | United States | $31.596B | 17.85 |
| Mettler-Toledo (MTD) | United States | $25.639B | 30.16 |
| STERIS (STE) | Ireland | $22.280B | 24.54 |
| Waters (WAT) | United States | $17.184B | 24.25 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.216B | 0.00 |
| Hologic (HOLX) | United States | $14.891B | 16.10 |
| Sysmex ADR (SSMXY) | Japan | $10.273B | 29.14 |
| Penumbra (PEN) | United States | $9.838B | 71.87 |
| Masimo (MASI) | United States | $8.338B | 30.76 |
| Globus Medical (GMED) | United States | $7.125B | 16.98 |
| Teleflex (TFX) | United States | $5.281B | 8.52 |
| Glaukos (GKOS) | United States | $4.919B | 0.00 |
| TransMedics (TMDX) | United States | $4.056B | 61.64 |
| Integer Holdings (ITGR) | United States | $3.802B | 18.97 |
| PROCEPT BioRobotics (PRCT) | United States | $2.684B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.300B | 13.70 |
| Nihon Kohden (NHNKY) | Japan | $1.918B | 22.00 |
| Elekta AB (EKTAY) | Sweden | $1.864B | 16.76 |
| Veracyte (VCYT) | United States | $1.841B | 25.83 |
| Alphatec Holdings (ATEC) | United States | $1.547B | 0.00 |
| Artivion (AORT) | United States | $1.320B | 123.64 |
| Tandem Diabetes Care (TNDM) | United States | $1.038B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.021B | 5.87 |
| OPKO Health (OPK) | United States | $1.015B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.010B | 0.00 |
| IRadimed (IRMD) | United States | $0.742B | 37.64 |
| Beta Bionics (BBNX) | United States | $0.730B | 0.00 |
| SiBone (SIBN) | United States | $0.726B | 0.00 |
| AxoGen (AXGN) | United States | $0.596B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.517B | 8.04 |
| OrthoPediatrics (KIDS) | United States | $0.503B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.494B | 10.64 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.421B | 9.78 |
| Pacific Biosciences Of California (PACB) | United States | $0.414B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.374B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.360B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.338B | 0.00 |
| RxSight (RXST) | United States | $0.316B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.291B | 0.00 |
| Neuronetics (STIM) | United States | $0.290B | 0.00 |
| NeuroPace (NPCE) | United States | $0.279B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| 908 Devices (MASS) | United States | $0.235B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.06 |
| CVRx (CVRX) | United States | $0.208B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.172B | 0.00 |
| Inogen (INGN) | United States | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Accuray (ARAY) | United States | $0.148B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.146B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.126B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.116B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.106B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.092B | 55.90 |
| InspireMD (NSPR) | United States | $0.085B | 0.00 |
| Hyperfine (HYPR) | United States | $0.083B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.081B | 0.00 |
| Spectral AI (MDAI) | United States | $0.063B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| Positron (POSC) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.053B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.052B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 20.33 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.013B | 0.00 | |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 14.48 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |